BRICKBIO
BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins. The company's platform can optimize any conjugate with the selective modification of a number of distinct websites on a single protein through its prokaryotic and eukaryotic expression programs, thereby providing hospitals with amino acid coupled therapeutics to improve protein characteristics.
BRICKBIO
Social Links:
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.brickbio.com
Total Employee:
1+
Status:
Active
Contact:
(212) 984-2548
Total Funding:
5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GStatic Google Static Content
Similar Organizations
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Current Employees Featured
Founder
Official Site Inspections
http://www.brickbio.com Semrush global rank: 5.8 M Semrush visits lastest month: 1.44 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "BrickBio"
BrickBio - Crunchbase Company Profile & Funding
BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins. The company's platform can optimize any conjugate with the selective …See details»
BrickBio Company Profile 2024: Valuation, Funding & Investors
When was BrickBio founded? BrickBio was founded in 2019. Where is BrickBio headquartered? BrickBio is headquartered in Waltham, MA. What is the size of BrickBio? BrickBio has 9 total …See details»
BrickBio, Inc. - LinkedIn
BrickBio, Inc. | 1,045 followers on LinkedIn. Any site. Any protein. Any conjugate. BrickBio's best-in-class protein bioconjugation platform.See details»
PIPELINE - Brickbio
BrickBio's engineered RNA and protein-chemistry platform technology enables custom tailoring of any protein with homogenous, site-specific and site-selective bioconjugation modifications, enabling novel classes of biologics with superior …See details»
BrickBio - Contacts, Employees, Board Members, Advisors & Alumni
BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins.See details»
BrickBio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 18, 2024: Venture Round - …See details»
BrickBio - VentureRadar
"BrickBio is a biotechnology company specializing in the development of precision biologics using an expanded genetic code. Their proprietary site-specific and site-selective platform allows for …See details»
Samsung Invests in BrickBio to Develop Advanced …
Mar 18, 2024 Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop advanced molecules and therapies using BrickBio's proprietary protein engineering technology for antibody-drug ...See details»
BrickBio Achieves Unprecedented Breakthrough in Cancer Therapy …
Mar 12, 2024 BrickBio is working with partners to develop best-in-class therapeutics and RUO kits with its proprietary bioconjugation strategies. BrickBio is expanding its therapeutic …See details»
BrickBio Obtains Exclusive License to “Pan Epitope” Site-Specific ...
Apr 12, 2019 Boston, Massachusetts - BrickBio, a company formed out of Tiger Gene has obtained a worldwide exclusive license, from Boston College, to Dr. Abhishek Chatterjee’s …See details»
BrickBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins. Search Crunchbase. Start Free Trial . ... These include …See details»
BrickBio Unveils Powerful Engineered RNA Therapeutic …
Apr 25, 2022 BrickBio is working with partners to develop best-in-class therapeutics and RUO kits with its proprietary bioconjugation strategies. BrickBio is expanding its therapeutic …See details»
Samsung Invests in BrickBio to Develop Advanced Molecules and …
Mar 18, 2024 Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop advanced molecules and therapies using BrickBio's proprietary protein engineering technology …See details»
BrickBio Unveils Powerful Engineered RNA Therapeutic …
Apr 25, 2022 BrickBio, the leader in RNA facilitated site- specific protein assembly, presented an invited poster at the annual meeting of the American Association of Cancer Research (AACR) …See details»
BrickBio Achieves Stable Cell Line in Record Timeframe: 5x Faster …
Feb 7, 2023 BrickBio has overcome previous limitations in unnatural amino acid (UAA) driven site-specific conjugation by achieving stable, mammalian cell lines 5x faster than previous …See details»
BrickBio Creates Novel Class of Bispecific Antibody Drug …
Jan 19, 2021 BrickBio is working with partners to develop best-in-class therapeutics and RUO kits with its proprietary bioconjugation strategies. BrickBio is expanding its therapeutic …See details»
Antibody-drug Combo Shows Early Promise in Targeting Breast …
Dec 17, 2020 BrickBio’s antibody-drug conjugate BRKB-28 showed preclinical effectiveness in eradicating breast cancer cells while leaving healthy cells unharmed, the company …See details»
BrickBio Achieves Stable Cell Line in Record Timeframe: 5x Faster …
BOSTON, February 7, 2023 /PRNewswire/ -- BrickBio Highlights Unique Advantages from the Proprietary "VADER" System, published on Dec 22, 2022 in Nature Methods, for Incorporation …See details»
BrickBio Achieves Unprecedented Breakthrough in Cancer Therapy …
WALTHAM, MA, USA I March 12, 2024 I BrickBio.com, a pioneering leader in ADC (antibody drug conjugates) with a wide toolkit ranging from site specific chemistries to accessibility to novel …See details»